Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1270-1277
Published online before print May 5, 2005, doi: 10.1161/01.STR.0000166023.51307.e0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/6/1270    most recent
01.STR.0000166023.51307.e0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petzold, G. C.
Right arrow Articles by Dreier, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petzold, G. C.
Right arrow Articles by Dreier, J. P.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Energy metabolism
Right arrow Ischemic biology - basic studies
Right arrow Acute Cerebral Infarction
Right arrow Brain Circulation and Metabolism
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage

(Stroke. 2005;36:1270.)
© 2005 American Heart Association, Inc.


Original Contributions

Increased Extracellular K+ Concentration Reduces the Efficacy of N-methyl-D-aspartate Receptor Antagonists to Block Spreading Depression-Like Depolarizations and Spreading Ischemia

Gabor C. Petzold, MD; Olaf Windmüller, MS; Stephan Haack, MS; Sebastian Major, MD; Katharina Buchheim, MD; Dirk Megow, PhD; Siegrun Gabriel, PhD; Thomas-Nicolas Lehmann, MD; Christoph Drenckhahn, MD; Oliver Peters, MD; Hartmut Meierkord, MD; Uwe Heinemann, MD; Ulrich Dirnagl, MD Jens P. Dreier, MD

From the Department of Neurology (G.C.P., S.M., K.B., C.D., H.M., U.D., J.P.D.) and the Department of Experimental Neurology (G.C.P., O.W., S.H., S.M., D.M., C.D., U.D.), Charité–University Medicine Berlin, Berlin, Germany; the Johannes Müller Institute of Physiology (S.G., U.H.), Charité–University Medicine Berlin, Berlin, Germany; the Department of Neurosurgery (T.-N.L.), Charité–University Medicine Berlin, Berlin, Germany; and the Department of Psychiatry (O.P.), Charité–University Medicine Berlin, Berlin, Germany.

Correspondence to Dr Jens P. Dreier, Department of Neurology, Charité–University Medicine Berlin, Schumannstr. 20/21, 10117 Berlin, Germany. E-mail jens.dreier{at}charite.de

Background and Purpose— Spreading depression (SD)-like depolarizations may augment neuronal damage in neurovascular disorders such as stroke and traumatic brain injury. Spreading ischemia (SI), a particularly malignant variant of SD-like depolarization, is characterized by inverse coupling between the spreading depolarization wave and cerebral blood flow. SI has been implicated in particular in the pathophysiology of subarachnoid hemorrhage. Under physiological conditions, SD is blocked by N-methyl-D-aspartate receptor (NMDAR) antagonists. However, because both SD-like depolarizations and SI occur in presence of an increased extracellular K+ concentration ([K+]o), we tested whether this increase in baseline [K+]o would reduce the efficacy of NMDAR antagonists.

Methods— Cranial window preparations, laser Doppler flowmetry, and K+-sensitive/reference microelectrodes were used to record SD, SD-like depolarizations, and SI in rats in vivo; microelectrodes and intrinsic optical signal measurements were used to record SD and SD-like depolarizations in human and rat brain slices.

Results— In vivo, the noncompetitive NMDAR antagonist dizocilpine (MK-801) blocked SD propagation under physiological conditions, but did not block SD-like depolarizations or SI under high baseline [K+]o. Similar results were found in human and rat neocortical slices with both MK-801 and the competitive NMDAR antagonist D-2-amino-5-phosphonovaleric acid.

Conclusions— Our data suggest that elevated baseline [K+]o reduces the efficacy of NMDAR antagonists on SD-like depolarizations and SI. In conditions of moderate energy depletion, as in the ischemic penumbra, or after subarachnoid hemorrhage, NMDAR inhibition may not be sufficient to block these depolarizations.


Key Words: brain injuries • N-methyl-D-aspartate • spreading cortical depression • stroke • subarachnoid hemorrhage • trauma




This article has been cited by other articles:


Home page
BrainHome page
J. P. Dreier, S. Major, A. Manning, J. Woitzik, C. Drenckhahn, J. Steinbrink, C. Tolias, A. I. Oliveira-Ferreira, M. Fabricius, J. A. Hartings, et al.
Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage
Brain, July 1, 2009; 132(7): 1866 - 1881.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. C. Petzold, S. Haack, O. von Bohlen und Halbach, J. Priller, T.-N. Lehmann, U. Heinemann, U. Dirnagl, and J. P. Dreier
Nitric Oxide Modulates Spreading Depolarization Threshold in the Human and Rodent Cortex * Supplemental Materials and Methods
Stroke, April 1, 2008; 39(4): 1292 - 1299.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. K. Pomper, S. Haack, G. C. Petzold, K. Buchheim, S. Gabriel, U. Hoffmann, and U. Heinemann
Repetitive Spreading Depression-Like Events Result in Cell Damage in Juvenile Hippocampal Slice Cultures Maintained in Normoxia
J Neurophysiol, January 1, 2006; 95(1): 355 - 368.
[Abstract] [Full Text] [PDF]